AdvaMed has submitted comments on the Center for Devices and Radiological Health's A- and B-lists of guidances to be published this fiscal year, noting that guidances on the Breakthrough Devices Program and the Special 510(k) Program are of high importance for the industry. AdvaMed also suggested moving four of the five final guidances on the B-list to the A-list, including a guidance on unique device identifier topics.
AdvaMed gives recommendations on CDRH's guidance priorities
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.